| Infectious Diseases - Reviving reservoirs: new findings shake up HIV treatment understanding |
|
|
|
|
| |
|
| |
The latest infectious diseases news from News Medical |
|
|
|
 | | |
 Announcing core reagents for HIV R&D!
The HIV-1 envelope glycoprotein (Env) is the most relevant target used to elicit an immune response against HIV. New research has highlighted the potential of using gp140 trimers for development that can eliminate non-neutralizing epitopes to be exposed. Explore ACRO's protein HIV antigens to help accelerate your research!
| |
|
|
|
|
| | |  Scientists have discovered new strains of malaria-causing parasites in Ethiopia that are both resistant to current treatments and evade detection by common diagnostic tests—a development that could increase malaria cases and deaths while making eradicating the disease even more difficult. | | | | |  Researchers at Karolinska Institute have developed a novel method using DNA Nanoballs to detect pathogens, aiming to simplify nucleic acid testing and revolutionize pathogen detection. | | | | |  The UK Health Security Agency (UKHSA) has published SARS-CoV-2 variant surveillance and assessment technical briefing 53. It contains the latest epidemiological and genomic analysis of the emergent BA.2.86 variant. | | | | |  The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects. | | | | |  Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health's Clinical Center in Bethesda, Maryland. | |
|
|
|
 | | | How would you rate today's newsletter?
| |
|
|
|
|
|
